Opko Health OPK
NASDAQ OPK
$1.73 +0.03 (+2.07%)
As of: Sep 22, 2026 · 11:37 AM EDT

Opko Health (OPK) Long-Term Investments (2010 - 2026)

Opko Health's (OPK) quarterly Long-Term Investments came in at $40.2 million in Q2 2026, up 208.29% on a YoY basis from $13.0 million in Q2 2025, and up 281.96% quarter-over-quarter from $10.5 million in Q1 2026.

Analysis

Opko Health (OPK) Long-Term Investments (2010 - 2026) Analysis & Trends

Opko Health (OPK) has reported Long-Term Investments for 17 consecutive years, with $40.2 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Long-Term Investments rose 208.29% year-over-year to $40.2 million; the trailing twelve-month figure through Jun 2026 stood at $40.2 million (up 208.29% YoY), and the FY2025 full-year result was $14.2 million, down 74.04% from the prior year.
  • Long-Term Investments rose to $40.2 million in Q2 2026 per OPK's latest filing, from $10.5 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $108.7 million in Q2 2022 and bottomed at $9.5 million in Q1 2022.
  • Historically, Long-Term Investments has averaged $40.6 million across 5 years, with a median of $27.9 million in 2022.
  • The sharpest annual moves came in 2022 and 2025: Long-Term Investments surged 1115.04% in 2022, then tumbled 87.15% in 2025.
  • Over 5 years, Long-Term Investments stood at $28.1 million in 2022, then plunged by 42.73% to $16.1 million in 2023, then surged by 239.41% to $54.6 million in 2024, then tumbled by 74.04% to $14.2 million in 2025, then soared by 183.86% to $40.2 million in 2026.
  • According to Business Quant data, Long-Term Investments over the past three periods registered $40.2 million, $10.5 million, and $14.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn -
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn 266.00 Mn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn 69.00 Mn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn 1.56 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn 397.00 Mn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn 3.73 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn - -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn -
10 Opko Health 1.25 Bn 945.61 Mn 80.02 Mn 40.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 40.22 Mn
Mar 31, 2026 10.53 Mn
Dec 31, 2025 14.17 Mn
Sep 30, 2025 13.37 Mn
Jun 30, 2025 13.05 Mn
Mar 31, 2025 12.75 Mn
Dec 31, 2024 54.58 Mn
Sep 30, 2024 100.61 Mn
Jun 30, 2024 101.49 Mn
Mar 31, 2024 40.99 Mn
Dec 31, 2023 16.08 Mn
Sep 30, 2023 19.38 Mn
Jun 30, 2023 27.78 Mn
Mar 31, 2023 41.23 Mn
Dec 31, 2022 28.08 Mn
Sep 30, 2022 77.80 Mn
Jun 30, 2022 108.69 Mn
Mar 31, 2022 9.47 Mn
Dec 31, 2021 10.73 Mn
Sep 30, 2021 11.75 Mn
API Access

Opko Health Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=OPK&period=max&api_key=YOUR_API_KEY